Health Care Expenditures of Medicare Beneficiaries with Normal Pressure Hydrocephalus.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 07 01 2019
revised: 18 03 2019
accepted: 19 03 2019
pubmed: 1 4 2019
medline: 24 1 2020
entrez: 1 4 2019
Statut: ppublish

Résumé

Normal pressure hydrocephalus (NPH) is an underdiagnosed and undertreated condition affecting the elderly population and with costs associated with its surgical management reported to be less than those associated with conservative management. To determine if the rate of diagnosis of NPH has improved over the last decade, the rate of treatment has increased, and if surgical treatment costs and socioeconomic factors related to receipt of treatment have changed over time compared with conservative therapy. A retrospective study based on data from a nationally representative random sample of 2,378,637 Medicare beneficiaries (2006-2010) was performed. Shunt surgery, shunt revision, replacement, and removal were analyzed as independent variables. A total of 2321 patients with NPH were included, with 580 (24.99%) receiving a first shunt procedure. The adjusted effect of the procedure is that total 5-year expenditures are $11,676 more per patient (P < 0.001) than expenditures associated with nonsurgical management. Shunt revision ($22,715, P < 0.01) and/or replacement ($46,607, P < 0.001) add significantly to 5-year expenditures. Socioeconomic factors including African American race (P = 0.006); age 75-79 years (P = 0.024), 80-84 years (P < 0.001), and ≥85 years (P < 0.001); and Medicaid (P < 0.001) have significant negative associations with shunt surgery. There was a 1.66-fold increase in the rate of diagnosis of NPH, from 0.12% in 1999 to 0.2% in 2008. The total costs per surgical patient rose by approximately 145% to 160% comparing 2001 and 2010. This increase was mainly due to hospital (by 167% to 168%) and home health costs (by 118% to 148%). Providing appropriate care across the socioeconomic spectrum warrants further study and requires identifying the factors that limit access to care.

Sections du résumé

BACKGROUND BACKGROUND
Normal pressure hydrocephalus (NPH) is an underdiagnosed and undertreated condition affecting the elderly population and with costs associated with its surgical management reported to be less than those associated with conservative management.
OBJECTIVE OBJECTIVE
To determine if the rate of diagnosis of NPH has improved over the last decade, the rate of treatment has increased, and if surgical treatment costs and socioeconomic factors related to receipt of treatment have changed over time compared with conservative therapy.
METHODS METHODS
A retrospective study based on data from a nationally representative random sample of 2,378,637 Medicare beneficiaries (2006-2010) was performed. Shunt surgery, shunt revision, replacement, and removal were analyzed as independent variables.
RESULTS RESULTS
A total of 2321 patients with NPH were included, with 580 (24.99%) receiving a first shunt procedure. The adjusted effect of the procedure is that total 5-year expenditures are $11,676 more per patient (P < 0.001) than expenditures associated with nonsurgical management. Shunt revision ($22,715, P < 0.01) and/or replacement ($46,607, P < 0.001) add significantly to 5-year expenditures. Socioeconomic factors including African American race (P = 0.006); age 75-79 years (P = 0.024), 80-84 years (P < 0.001), and ≥85 years (P < 0.001); and Medicaid (P < 0.001) have significant negative associations with shunt surgery.
CONCLUSIONS CONCLUSIONS
There was a 1.66-fold increase in the rate of diagnosis of NPH, from 0.12% in 1999 to 0.2% in 2008. The total costs per surgical patient rose by approximately 145% to 160% comparing 2001 and 2010. This increase was mainly due to hospital (by 167% to 168%) and home health costs (by 118% to 148%). Providing appropriate care across the socioeconomic spectrum warrants further study and requires identifying the factors that limit access to care.

Identifiants

pubmed: 30928595
pii: S1878-8750(19)30881-2
doi: 10.1016/j.wneu.2019.03.201
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e548-e555

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Phoebe Sharkey (P)

Department of Neurosurgery, Sellinger School of Business, Loyola University Maryland, Baltimore, Maryland, USA.

Gabriel Pinilla-Monsalve (G)

Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA.

Alessandra Rigamonti (A)

Department of Neurosurgery, Cornell University, Ithaca, New York, USA.

Kathryn Carson (K)

Department of Neurosurgery, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.

Jamie Robison (J)

Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA.

Tito Vivas-Buitrago (T)

Faculty of Health Sciences, School of Medicine, Universidad de Santander UDES, Bucaramanga, Colombia, USA; Department of Neurosurgery, Mayo Clinic, Jacksonville, Florida, USA.

Ignacio Jusué-Torres (I)

Department of Neurosurgery, Loyola University Chicago, Maywood, Illinois, USA.

Gwendolyn Clemens (G)

Department of Neurosurgery, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.

Abanti Sanyal (A)

Department of Neurosurgery, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.

Jamie Hoffberger (J)

Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA.

Eric W Sankey (EW)

Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA.

Jennifer Lu (J)

Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA.

Atif Adams (A)

Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA.

Daniele Rigamonti (D)

Department of Neurosurgery, Johns Hopkins University, Baltimore, Maryland, USA. Electronic address: daniele.rigamonti@jhah.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH